Clinical Trials Directory

Trials / Completed

CompletedNCT03259282

Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis

Status
Completed
Phase
Study type
Observational
Enrollment
78 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Evaluation of the rate of achievement of serum protein electrophoresis (PPE) in diagnosis in a retrospective cohort of patients at Rennes University Hospital

Detailed description

In 50% of cases, sarcoidosis is associated with polyclonal hypergammaglobulinemia. The other forms have a normal gamma globulin level. The level of gamma globulinemia has not yet been studied as an evolutionary predictive factor. Furthermore, there are disseminated granulomatoses sharing common characteristics with sarcoidosis, associated with Common Variable Immunodeficiency deficit (DICV) type Primary Immunodeficiency syndrome (DIP), thus occurring in hypogammaglobulinemic patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAnalysis of gamma globulinElectrophoresis of proteins

Timeline

Start date
2017-03-07
Primary completion
2017-03-22
Completion
2017-03-22
First posted
2017-08-23
Last updated
2018-04-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03259282. Inclusion in this directory is not an endorsement.